CCL4 and myeloid sarcoma: CCL4 overexpression in the brain has been reported in a number of diseases including MS (Subileau et al., 2009), AD (Zhu et al., 2014) and PD (Calvani, 2020), and as such may impact on disease progression by causing, amongst other effects, BBB dysfunction.